Results of analysis of factors of adverse development of lymphograngulematosis as a basis for organization of effective pharmaceutical provision for oncohematological patients
JavaScript is disabled for your browser. Some features of this site may not work without it.
Results of analysis of factors of adverse development of lymphograngulematosis as a basis for organization of effective pharmaceutical provision for oncohematological patients